Clinical Trial Update: Clinical Evaluation of the New Hypoxia Imaging Agent HX4 [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of Phase 1 and Phase 2 clinical evaluation of the hypoxia imaging agent HX4 in cancers including head and neck, lung, and l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Liver Cancer
• Lung Cancer

Drugs mentioned

• HX4

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Head and Neck Cancer, Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED